Ray Dalio Invitae Corp Transaction History

Bridgewater Associates, LP

  • $18.9 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$1.71 - $3.61 $453,288 - $956,942
-265,081 Reduced 73.15%
97,318 $181,000
Q3 2022

Nov 10, 2022
BUY
$1.9 - $8.63 $19,647 - $89,242
10,341 Added 2.94%
362,399 $892,000
Q2 2022

Aug 11, 2022
BUY
$2.13 - $9.01 $109,298 - $462,339
51,314 Added 17.06%
352,058 $859,000
Q1 2022

May 13, 2022
BUY
$6.28 - $15.59 $1.89 Million - $4.69 Million
300,744 New
300,744 $2.4 Million

Others Institutions Holding NVTA

# of Institutions
38
Shares Held
2.12M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email